Using Flexible Cohort Management to Enable Creativity in Oncology Designs
Download this position paper to learn:
How flexible cohort management can enable complex oncology designs
5 key capabilities of cohort management necessary to support creativity
Importance of both control and flexibility in cohort management
Benefits of an integrated supply forecasting engine to reduce overage
Share
Download the white paper
The FDA is making a considerable effort to drive efficiencies in clinical trial research, especially when it comes to oncology studies. In 2017 alone, there were 46 new oncology drugs approved by the FDA, including 18 Fast Track Designated products and 17 Break-Through therapies.
White Paper